Oramed Pharmaceuticals
ORMP
#9090
Rank
โ‚น10.89 B
Marketcap
โ‚น273.51
Share price
4.66%
Change (1 day)
28.39%
Change (1 year)

Oramed Pharmaceuticals (ORMP) - Total liabilities

Total liabilities on the balance sheet as of June 2025 : โ‚น0.73 Billion

According to Oramed Pharmaceuticals's latest financial reports the company's total liabilities are โ‚น0.73 Billion. A companyโ€™s total liabilities is the sum of all current and non-current debts and obligations.

Oramed Pharmaceuticals - Total liabilities on balance sheet (from 2005 to 2025)

Total liabilities by year

Year Total liabilities Change
2024-12-31โ‚น0.85 B-82.25%
2023-12-31โ‚น4.79 B453.17%
2022-12-31โ‚น0.86 B
2021-08-31โ‚น0.83 B-3.21%
2020-08-31โ‚น0.86 B-20.95%
2019-08-31โ‚น1.09 B-5.1%
2018-08-31โ‚น1.15 B-7.25%
2017-08-31โ‚น1.24 B11.68%
2016-08-31โ‚น1.11 B1000.7%
2015-08-31โ‚น0.10 B65.83%
2014-08-31โ‚น61.05 M73.08%
2013-08-31โ‚น35.27 M-58.2%
2012-08-31โ‚น84.39 M206.47%
2011-08-31โ‚น27.53 M-5.65%
2010-08-31โ‚น29.18 M15.96%
2009-08-31โ‚น25.16 M-37.38%
2008-08-31โ‚น40.19 M-31.44%
2007-08-31โ‚น58.61 M106.99%
2006-08-31โ‚น28.31 M1300.28%
2005-08-31โ‚น2.02 M

Total liabilities for similar companies or competitors

Company Total liabilities differencediff. Country
Ultragenyx Pharmaceutical
RARE
โ‚น105.82 B 14,395.62%๐Ÿ‡บ๐Ÿ‡ธ USA
Novo Nordisk
NVO
โ‚น4.851 T 664,499.43%๐Ÿ‡ฉ๐Ÿ‡ฐ Denmark
Sanofi
SNY
โ‚น5.950 T 814,948.76%๐Ÿ‡ซ๐Ÿ‡ท France
Compugen
CGEN
โ‚น4.86 B 566.82%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel
Lexicon Pharmaceuticals
LXRX
โ‚น7.72 B 958.73%๐Ÿ‡บ๐Ÿ‡ธ USA